Overview

Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

Status:
Terminated

Trial end date:
2020-09-15

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the efficacy, tolerability, safety and pharmacokinetics of Oxymorphone HCl as an analgesic for acute moderate to severe post-operative pain in pediatric subjects.

Phase:

Phase 3

Details

Lead Sponsor:

Endo Pharmaceuticals

Treatments:

Oxymorphone